Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients

BACKGROUND: Adjuvant therapy decisions may be partly based on the results of a multigene quantitative reverse transcription-polymerase chain reaction (RT-PCR)-based assay: the 21-gene recurrence score (RS) test of resection specimens. When necessary, core needle biopsy (CNB) may be considered as a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Peng, Yang, Yu, Bai, Qian-ming, Xue, Tian, Ren, Min, Yao, Qian-lan, Yang, Wen-tao, Zhou, Xiao-yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804587/
https://www.ncbi.nlm.nih.gov/pubmed/33439420
http://dx.doi.org/10.1007/s10549-020-06075-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804587/
https://www.ncbi.nlm.nih.gov/pubmed/33439420
http://dx.doi.org/10.1007/s10549-020-06075-6

Ejemplares similares